Other
Some Human Data
Approved (Vyleesi)
PT-141
Bremelanotide / Vyleesi
FDA-approved for hypoactive sexual desire disorder (HSDD) in premenopausal women. Works through the brain, not blood flow.
Quick Facts
Amino Acids
7
Route
subcutaneous
Evidence
Some Human Data
FDA Status
Approved (Vyleesi)
Mechanism of Action
Melanocortin-4 receptor (MC4R) agonist -- acts on the central nervous system to increase sexual desire